Lilly’s stock rallies as sales of GLP-1 drugs nearly double

Europe’s top banks have set aside hundreds of millions of euros to shield against a financial impact from the Iran war, highlighting how the economic risks for the region are on the rise.

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.

US Treasuries gained as Brent crude prices retreated from a four-year high, though simmering inflation fears kept yields near their recent peaks.

Military operations have impacted sections of a sprawling European fuel pipeline network at a time of supply pressures caused by the Iran war, according to a German service provider for the system.